320 related articles for article (PubMed ID: 15972086)
1. Zonisamide in the treatment of painful diabetic neuropathy: a randomized, double-blind, placebo-controlled pilot study.
Atli A; Dogra S
Pain Med; 2005; 6(3):225-34. PubMed ID: 15972086
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens.
Wymer JP; Simpson J; Sen D; Bongardt S;
Clin J Pain; 2009 Jun; 25(5):376-85. PubMed ID: 19454870
[TBL] [Abstract][Full Text] [Related]
3. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
4. Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study.
Rauck RL; Shaibani A; Biton V; Simpson J; Koch B
Clin J Pain; 2007 Feb; 23(2):150-8. PubMed ID: 17237664
[TBL] [Abstract][Full Text] [Related]
5. Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study.
Thisted RA; Klaff L; Schwartz SL; Wymer JP; Culligan NW; Gerard G; Pope LE; Berg JE
Clin Ther; 2006 Oct; 28(10):1607-18. PubMed ID: 17157116
[TBL] [Abstract][Full Text] [Related]
6. The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus.
Kadiroglu AK; Sit D; Kayabasi H; Tuzcu AK; Tasdemir N; Yilmaz ME
J Diabetes Complications; 2008; 22(4):241-5. PubMed ID: 18413214
[TBL] [Abstract][Full Text] [Related]
7. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial.
Lee EY; Lee EB; Park BJ; Lee CK; Yoo B; Lim MK; Shim SC; Sheen DH; Seo YI; Kim HA; Baek HJ; Song YW
Clin Ther; 2006 Dec; 28(12):2052-60. PubMed ID: 17296461
[TBL] [Abstract][Full Text] [Related]
8. Long-term oral lacosamide in painful diabetic neuropathy: a two-year open-label extension trial.
Shaibani A; Biton V; Rauck R; Koch B; Simpson J
Eur J Pain; 2009 May; 13(5):458-63. PubMed ID: 18619874
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R
Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
[TBL] [Abstract][Full Text] [Related]
10. Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial.
Shaibani A; Fares S; Selam JL; Arslanian A; Simpson J; Sen D; Bongardt S
J Pain; 2009 Aug; 10(8):818-28. PubMed ID: 19409861
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
[TBL] [Abstract][Full Text] [Related]
12. Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy.
Freeman R; Raskin P; Hewitt DJ; Vorsanger GJ; Jordan DM; Xiang J; Rosenthal NR;
Curr Med Res Opin; 2007 Jan; 23(1):147-61. PubMed ID: 17257476
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of painful diabetic peripheral neuropathy among patients suffering from diabetes mellitus in Saudi Arabia.
Halawa MR; Karawagh A; Zeidan A; Mahmoud AE; Sakr M; Hegazy A
Curr Med Res Opin; 2010 Feb; 26(2):337-43. PubMed ID: 19968592
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
[TBL] [Abstract][Full Text] [Related]
15. Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.
Hurwitz BJ; Jeffery D; Arnason B; Bigley K; Coyle P; Goodin D; Kaba S; Kirzinger S; Lynch S; Mandler R; Mikol D; Rammohan K; Sater R; Sriram S; Thrower B; Boateng F; Jakobs P; Wash MB; Bogumil T
Clin Ther; 2008 Jun; 30(6):1102-12. PubMed ID: 18640466
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
17. Critical review of oral drug treatments for diabetic neuropathic pain-clinical outcomes based on efficacy and safety data from placebo-controlled and direct comparative studies.
Adriaensen H; Plaghki L; Mathieu C; Joffroy A; Vissers K
Diabetes Metab Res Rev; 2005; 21(3):231-40. PubMed ID: 15858788
[TBL] [Abstract][Full Text] [Related]
18. Utilization of zonisamide in patients with chronic pain or epilepsy refractory to other treatments: a retrospective, open label, uncontrolled study in a VA hospital.
Hasegawa H
Curr Med Res Opin; 2004 May; 20(5):577-80. PubMed ID: 15140322
[TBL] [Abstract][Full Text] [Related]
19. A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report.
Valensi P; Le Devehat C; Richard JL; Farez C; Khodabandehlou T; Rosenbloom RA; LeFante C
J Diabetes Complications; 2005; 19(5):247-53. PubMed ID: 16112498
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.
Yuan RY; Sheu JJ; Yu JM; Chen WT; Tseng IJ; Chang HH; Hu CJ
Neurology; 2009 Apr; 72(17):1473-8. PubMed ID: 19246421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]